Skip to main content

Advertisement

SpringerLink
Log in

A split-face comparison of fractional erbium: YAG laser plus Kligman’s formula vs. Kligman’s formula monotherapy for facial melasma

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Melasma is a chronic hyperpigmentation disorder. Although several treatment methods are used for patients, it remains a challenging problem for physicians. Erbium-YAG laser is one of the laser treatment methods that proved its efficacy in melasma treatment. We aimed to compare the efficacy of combining the fractional Er: YAG laser and Kligman’s formula with Kligman’s formula alone in the treatment of melasma. Twenty female patients with bilateral melasma were randomly treated in a split-face controlled manner with a fractional Er: YAG laser followed by Kligman’s formula on one side and Kligman’s formula on the other side. All patients received three laser sessions with four-week intervals. The efficacy of treatments was determined through photographs, Visioface, and Melasma Area Severity Index (MASI) score, all performed at baseline and three months after the end of laser sessions. Fractional Er: YAG laser and Kligman’s formula showed a significant decrease in MASI score than Kligman’s formula alone (P = 0.005). There was a significant decrease in cheek Visioface score on Er: YAG laser and Kligman’s formula vs Kligman’s formula (P = 0.02). However, the Patient Global Assessment Scale of both sides was not statistically significant (P = 0.23). The combination of Fractional Er: YAG laser with Kligman’s formula is an effective treatment method for melasma.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Rigopoulos D, Gregoriou S, Katsambas A (2007) Hyperpigmentation and melasma. J Cosmet Dermatol 6(3):195–202. https://doi.org/10.1111/j.1473-2165.2007.00321.x (PubMed PMID: 17760699)

    Article  CAS  PubMed  Google Scholar 

  2. Balkrishnan R, McMichael AJ, Camacho FT et al (2003) Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol 149(3):572–577. https://doi.org/10.1046/j.1365-2133.2003.05419.x (PubMed PMID: 14510991)

    Article  CAS  PubMed  Google Scholar 

  3. Ball Arefiev KL, Hantash BM (2012) Advances in the treatment of melasma: a review of the recent literature. Dermatol Surg Off Publ Am Soc Dermatol Surg 38(7 Pt 1):971–984. https://doi.org/10.1111/j.1524-4725.2012.02435.x (PubMed PMID: 22583339)

    Article  CAS  Google Scholar 

  4. Ortonne JP, Passeron T (2005) Melanin pigmentary disorders: treatment update. Dermatol Clin 23(2):209–226. https://doi.org/10.1016/j.det.2005.01.001 (PubMed PMID: 15837152)

    Article  PubMed  Google Scholar 

  5. Morais OO, Lemos ÉF, Sousa MC et al (2013) The use of ablative lasers in the treatment of facial melasma. An Bras Dermatol 88(2):238–242. https://doi.org/10.1590/s0365-05962013000200009 (PubMedPMID:23739704;PubMedCentralPMCID:PMCPMC3750887)

    Article  PubMed  PubMed Central  Google Scholar 

  6. Badawi AM, Osman MA (2018) Fractional erbium-doped yttrium aluminum garnet laser-assisted drug delivery of hydroquinone in the treatment of melasma. Clin Cosmet Investig Dermatol 11:13–20. https://doi.org/10.2147/ccid.s147413 (PubMedPMID:29379308;PubMedCentralPMCID:PMCPMC5757209)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Attwa E, Khater M, Assaf M et al (2015) Melasma treatment using an erbium:YAG laser: a clinical, immunohistochemical, and ultrastructural study. Int J Dermatol 54(2):235–244. https://doi.org/10.1111/ijd.12477 (PubMed PMID: 25266556)

    Article  PubMed  Google Scholar 

  8. Alavi S, Abolhasani E, Asadi S et al (2017) Combination of Q-switched Nd:YAG and fractional erbium:YAG lasers in treatment of melasma: a randomized controlled clinical trial. J Lasers Med Sci 8(1):1–6. https://doi.org/10.15171/jlms.2017.01 (PubMed PMID: 28912936; PubMed Central PMCID: PMCPMC5420358)

    Article  PubMed  PubMed Central  Google Scholar 

  9. Abdel-Raouf Mohamed H, Ali Nasif G, Saad Abdel-Azim E et al (2019) Comparative study of fractional Erbium: YAG laser vs combined therapy with topical steroid as an adjuvant treatment in melasma. J Cosmet Dermatol 18(2):517–523. https://doi.org/10.1111/jocd.12751 (PubMed PMID: 30146730)

    Article  PubMed  Google Scholar 

  10. Erlendsson AM, Anderson RR, Manstein D et al (2014) Developing technology: ablative fractional lasers enhance topical drug delivery. Dermatol Surg Off Publ Am Soc Dermatol Surg 40:S142–S146. https://doi.org/10.1097/dss.0000000000000207 (PubMed PMID: 25417565)

    Article  Google Scholar 

  11. Manstein D, Herron GS, Sink RK et al (2004) Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 34(5):426–438. https://doi.org/10.1002/lsm.20048 (PubMed PMID: 15216537)

    Article  PubMed  Google Scholar 

  12. Pandya AG, Hynan LS, Bhore R et al (2011) Reliability assessment and validation of the melasma area and severity index (MASI) and a new modified MASI scoring method. J Am Acad Dermatol 64(1):78–83. https://doi.org/10.1016/j.jaad.2009.10.051 (PubMed PMID: 20398960)

    Article  PubMed  Google Scholar 

  13. Vázquez M, Maldonado H, Benmamán C et al (1988) Melasma in men. A clinical and histologic study. Int J Dermatol 27(1):25–27. https://doi.org/10.1111/j.1365-4362.1988.tb02329.x (PubMed PMID: 3346120)

    Article  PubMed  Google Scholar 

  14. Rokhsar CK, Fitzpatrick RE (2005) The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg Off Publ Am Soc Dermatol Surg 31(12):1645–1650. https://doi.org/10.2310/6350.2005.31302 (PubMed PMID: 16336881)

    Article  CAS  Google Scholar 

  15. Kim HS, Kim EK, Jung KE et al (2013) A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin. J Cosmetic Laser Ther Off Publ Eur Soc Laser Dermatol 15(3):143–149. https://doi.org/10.3109/14764172.2013.769274 (PubMed PMID: 23607714)

    Article  Google Scholar 

  16. BogdanAllemann I, Kaufman J (2010) Fractional photothermolysis–an update. Lasers Med Sci 25(1):137–144. https://doi.org/10.1007/s10103-009-0734-8 (PubMed PMID: 19787413)

    Article  Google Scholar 

  17. Namazi N, Hesami A, Ketabi Y (2020) The split-face comparison of the combined Er-YAG laser and hydroquinone 4% with hydroquinone 4% alone in the treatment of melasma in iranian patients: a prospective, interventional case study. J Lasers Med Sci 11(1):70–73. https://doi.org/10.15171/jlms.2020.12 (PubMed PMID: 32099630; PubMed Central PMCID: PMCPMC7008736)

    Article  PubMed  PubMed Central  Google Scholar 

  18. Otb S, Shaarawy E, Sadek A et al (2020) A split face comparative study between intradermal tranexamic acid and erbium-YAG laser in treatment of melasma. J Dermatolog Treat 18:1–22. https://doi.org/10.1080/09546634.2020.1771259 (PubMed PMID: 32420770)

    Article  CAS  Google Scholar 

  19. Vaiyavatjamai P, Wattanakrai P (2011) Side effects and complications of fractional 1550-nm erbium fiber laser treatment among Asians. J Cosmet Dermatol 10(4):313–316. https://doi.org/10.1111/j.1473-2165.2011.00585.x (PubMed PMID: 22151942)

    Article  PubMed  Google Scholar 

  20. Wanitphakdeedecha R, Manuskiatti W, Siriphukpong S et al (2009) Treatment of melasma using variable square pulse Er:YAG laser resurfacing. Dermatol surg off publ Am Soc Dermatol Surg 35(3):475–481. https://doi.org/10.1111/j.1524-4725.2009.01066.x (PubMed PMID: 19250309)

    Article  CAS  Google Scholar 

Download references

Funding

This study has been funded and supported by Tehran University of Medical Sciences (TUMS); Grant No: 98-02-30-40382.

Author information

Authors and Affiliations

  1. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Maryam Nasimi, Maryam Ghiasi, Vahideh Lajevardi & Fatemeh Nasiri

  2. Department of Dermatology, Imam Khomeini Hospital, Tehran University of Medical Sciences, 1419733141, Tehran, Iran

    Safoura Shakoei

Authors
  1. Maryam Nasimi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maryam Ghiasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vahideh Lajevardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fatemeh Nasiri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Safoura Shakoei
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Safoura Shakoei.

Ethics declarations

Conflict of interest

No conflict of interest.

Informed consent

Patient consent for publication is achieved.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nasimi, M., Ghiasi, M., Lajevardi, V. et al. A split-face comparison of fractional erbium: YAG laser plus Kligman’s formula vs. Kligman’s formula monotherapy for facial melasma. Arch Dermatol Res 314, 791–797 (2022). https://doi.org/10.1007/s00403-021-02294-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-021-02294-z

Keywords

Search

Navigation